                               SEQUENCE LISTING

<110> BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
 
<120> METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF

<130> UTSC.P1178WO-1001120862

<140> PCT/US2020/027516
<141> 2020-04-09

<150> 62/833,174
<151> 2019-04-12

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 856
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
atggatgact ccacagaaag ggagcagtca cgccttactt cttgccttaa gaaaagagaa       60

gaaatgaaac tgaaggagtg tgtttccatc ctcccacgga aggaaagccc ctctgtccga      120

tcctccaaag acggaaagct gctggctgca accttgctgc tggcactgct gtcttgctgc      180

ctcacggtgg tgtctttcta ccaggtggcc gccctgcaag gggacctggc cagcctccgg      240

gcagagctgc agggccacca cgcggagaag ctgccagcag gagcaggagc ccccaaggcc      300

ggcctggagg aagctccagc tgtcaccgcg ggactgaaaa tctttgaacc accagctcca      360

ggagaaggca actccagtca gaacagcaga aataagcgtg ccgttcaggg tccagaagaa      420

acagtcactc aagactgctt gcaactgatt gcagacagtg aaacaccaac tatacaaaaa      480

ggatcttaca catttgttcc atggcttctc agctttaaaa ggggaagtgc cctagaagaa      540

aaagagaata aaatattggt caaagaaact ggttactttt ttatatatgg tcaggtttta      600

tatactgata agacctacgc catgggacat ctaattcaga ggaagaaggt ccatgtcttt      660

ggggatgaat tgagtctggt gactttgttt cgatgtattc aaaatatgcc tgaaacacta      720

cccaataatt cctgctattc agctggcatt gcaaaactgg aagaaggaga tgaactccaa      780

cttgcaatac caagagaaaa tgcacaaata tcactggatg gagatgtcac attttttggt      840

gcattgaaac tgctgc                                                      856


<210> 2
<211> 787
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 2
atgatcgaaa catacaacca aacttctccc cgatctgcgg ccactggact gcccatcagc       60

atgaaaattt ttatgtattt acttactgtt tttcttatca cccagatgat tgggtcagca      120

ctttttgctg tgtatcttca tagaaggctg gacaagatag aagatgaaag gaatcttcat      180

gaagattttg tattcatgaa aacgatacag agatgcaaca caggagaaag atccttatcc      240

ttactgaact gtgaggagat taaaagccag tttgaaggct ttgtgaagga tataatgtta      300

aacaaagagg aaacgaagaa agaaaacagc tttgaaatgc aaaaaggtga tcagaatcct      360

caaattgcgg cacatgtcat aagtgaggcc agcagtaaaa caacatctgt gttacagtgg      420

gctgaaaaag gatactacac catgagcaac aacttggtaa ccctggaaaa tgggaaacag      480

ctgaccgtta aaagacaagg actctattat atctatgccc aagtcacctt ctgttccaat      540

cgggaagctt cgagtcaagc tccatttata gccagcctct gcctaaagtc ccccggtaga      600

ttcgagagaa tcttactcag agctgcaaat acccacagtt ccgccaaacc ttgcgggcaa      660

caatccattc acttgggagg agtatttgaa ttgcaaccag gtgcttcggt gtttgtcaat      720

gtgactgatc caagccaagt gagccatggc actggcttca cgtcctttgg cttactcaaa      780

ctcggac                                                                787


<210> 3
<211> 512
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 3
gcatgagatc cagtcctggc aacatggaga ggattgtcat ttgtctgatg gtcattttct       60

tggggacact ggtccacaaa tcaagctccc aaggtcaaga tcgccacatg attaggatgc      120

gtcaacttat agatattgtt gatcagctga aaaattatgt gaatgacttg gtccctgaat      180

ttctgccagc tccagaagat gtagagacaa actgtgagtg gtcagctttt tcctgttttc      240

agaaggccca actaaagtca gcaaatacag gaaacaatga aaggataatc aatgtatcaa      300

ttaaaaagct gaagaggaaa ccaccttcca caaatgcagg gagaagacag aaacacagac      360

taacatgccc ttcatgtgat tcttatgaga aaaaaccacc caaagaattc ctagaaaggt      420

tcaaatcact tctccaaaag atgattcatc agcatctgtc ctctagaaca cacggaagtg      480

aagattcctg agatgatcat caacaccagc tg                                    512


<210> 4
<211> 285
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Met Asp Asp Ser Thr Glu Arg Glu Gln Ser Arg Leu Thr Ser Cys Leu 
1               5                   10                  15      


Lys Lys Arg Glu Glu Met Lys Leu Lys Glu Cys Val Ser Ile Leu Pro 
            20                  25                  30          


Arg Lys Glu Ser Pro Ser Val Arg Ser Ser Lys Asp Gly Lys Leu Leu 
        35                  40                  45              


Ala Ala Thr Leu Leu Leu Ala Leu Leu Ser Cys Cys Leu Thr Val Val 
    50                  55                  60                  


Ser Phe Tyr Gln Val Ala Ala Leu Gln Gly Asp Leu Ala Ser Leu Arg 
65                  70                  75                  80  


Ala Glu Leu Gln Gly His His Ala Glu Lys Leu Pro Ala Gly Ala Gly 
                85                  90                  95      


Ala Pro Lys Ala Gly Leu Glu Glu Ala Pro Ala Val Thr Ala Gly Leu 
            100                 105                 110         


Lys Ile Phe Glu Pro Pro Ala Pro Gly Glu Gly Asn Ser Ser Gln Asn 
        115                 120                 125             


Ser Arg Asn Lys Arg Ala Val Gln Gly Pro Glu Glu Thr Val Thr Gln 
    130                 135                 140                 


Asp Cys Leu Gln Leu Ile Ala Asp Ser Glu Thr Pro Thr Ile Gln Lys 
145                 150                 155                 160 


Gly Ser Tyr Thr Phe Val Pro Trp Leu Leu Ser Phe Lys Arg Gly Ser 
                165                 170                 175     


Ala Leu Glu Glu Lys Glu Asn Lys Ile Leu Val Lys Glu Thr Gly Tyr 
            180                 185                 190         


Phe Phe Ile Tyr Gly Gln Val Leu Tyr Thr Asp Lys Thr Tyr Ala Met 
        195                 200                 205             


Gly His Leu Ile Gln Arg Lys Lys Val His Val Phe Gly Asp Glu Leu 
    210                 215                 220                 


Ser Leu Val Thr Leu Phe Arg Cys Ile Gln Asn Met Pro Glu Thr Leu 
225                 230                 235                 240 


Pro Asn Asn Ser Cys Tyr Ser Ala Gly Ile Ala Lys Leu Glu Glu Gly 
                245                 250                 255     


Asp Glu Leu Gln Leu Ala Ile Pro Arg Glu Asn Ala Gln Ile Ser Leu 
            260                 265                 270         


Asp Gly Asp Val Thr Phe Phe Gly Ala Leu Lys Leu Leu 
        275                 280                 285 


<210> 5
<211> 262
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Leu Lys Met Ile Glu Thr Tyr Asn Gln Thr Ser Pro Arg Ser Ala Ala 
1               5                   10                  15      


Thr Gly Leu Pro Ile Ser Met Lys Ile Phe Met Tyr Leu Leu Thr Val 
            20                  25                  30          


Phe Leu Ile Thr Gln Met Ile Gly Ser Ala Leu Phe Ala Val Tyr Leu 
        35                  40                  45              


His Arg Arg Leu Asp Lys Ile Glu Asp Glu Arg Asn Leu His Glu Asp 
    50                  55                  60                  


Phe Val Phe Met Lys Thr Ile Gln Arg Cys Asn Thr Gly Glu Arg Ser 
65                  70                  75                  80  


Leu Ser Leu Leu Asn Cys Glu Glu Ile Lys Ser Gln Phe Glu Gly Phe 
                85                  90                  95      


Val Lys Asp Ile Met Leu Asn Lys Glu Glu Thr Lys Lys Glu Asn Ser 
            100                 105                 110         


Phe Glu Met Gln Lys Gly Asp Gln Asn Pro Gln Ile Ala Ala His Val 
        115                 120                 125             


Ile Ser Glu Ala Ser Ser Lys Thr Thr Ser Val Leu Gln Trp Ala Glu 
    130                 135                 140                 


Lys Gly Tyr Tyr Thr Met Ser Asn Asn Leu Val Thr Leu Glu Asn Gly 
145                 150                 155                 160 


Lys Gln Leu Thr Val Lys Arg Gln Gly Leu Tyr Tyr Ile Tyr Ala Gln 
                165                 170                 175     


Val Thr Phe Cys Ser Asn Arg Glu Ala Ser Ser Gln Ala Pro Phe Ile 
            180                 185                 190         


Ala Ser Leu Cys Leu Lys Ser Pro Gly Arg Phe Glu Arg Ile Leu Leu 
        195                 200                 205             


Arg Ala Ala Asn Thr His Ser Ser Ala Lys Pro Cys Gly Gln Gln Ser 
    210                 215                 220                 


Ile His Leu Gly Gly Val Phe Glu Leu Gln Pro Gly Ala Ser Val Phe 
225                 230                 235                 240 


Val Asn Val Thr Asp Pro Ser Gln Val Ser His Gly Thr Gly Phe Thr 
                245                 250                 255     


Ser Phe Gly Leu Leu Lys 
            260         


<210> 6
<211> 163
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Arg Met Arg Ser Ser Pro Gly Asn Met Glu Arg Ile Val Ile Cys Leu 
1               5                   10                  15      


Met Val Ile Phe Leu Gly Thr Leu Val His Lys Ser Ser Ser Gln Gly 
            20                  25                  30          


Gln Asp Arg His Met Ile Arg Met Arg Gln Leu Ile Asp Ile Val Asp 
        35                  40                  45              


Gln Leu Lys Asn Tyr Val Asn Asp Leu Val Pro Glu Phe Leu Pro Ala 
    50                  55                  60                  


Pro Glu Asp Val Glu Thr Asn Cys Glu Trp Ser Ala Phe Ser Cys Phe 
65                  70                  75                  80  


Gln Lys Ala Gln Leu Lys Ser Ala Asn Thr Gly Asn Asn Glu Arg Ile 
                85                  90                  95      


Ile Asn Val Ser Ile Lys Lys Leu Lys Arg Lys Pro Pro Ser Thr Asn 
            100                 105                 110         


Ala Gly Arg Arg Gln Lys His Arg Leu Thr Cys Pro Ser Cys Asp Ser 
        115                 120                 125             


Tyr Glu Lys Lys Pro Pro Lys Glu Phe Leu Glu Arg Phe Lys Ser Leu 
    130                 135                 140                 


Leu Gln Lys Met Ile His Gln His Leu Ser Ser Arg Thr His Gly Ser 
145                 150                 155                 160 


Glu Asp Ser 
            


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
tccatgacgt tcctgatgct                                                   20


<210> 8
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
tcgtcgtttt gtcgttttgt cgtt                                              24


